Bay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials Post author:Sam Post published:February 7, 2018 Post category:BioPharma Rani said the latest funding round brings its coffers a total of $142M. Source: BioSpace You Might Also Like FDA Slaps Clinical Hold on Solid Bioscience DMD Gene Therapy Program March 14, 2018 BioSpace Partners With To Offer Cost Savings To Members July 11, 2017 Stock Plunges Despite Biohaven's Positive Migraine Data March 25, 2018
